Nanoplasmonic Detection of Tumor-Derived EVs from 1 μL Plasma
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting tumor-derived extracellular vesicles (EVs) as cancer biomarkers are labor-intensive, require large sample volumes, and lack specificity, making them impractical for clinical and research use, especially in limited sample scenarios like animal models.
Innovation Solution
A nanoplasmon-enhanced scattering (nPES) assay using antibody-conjugated nanoparticles to form nanoplasmons for sensitive and specific detection of EVs, allowing direct analysis from small sample volumes without purification, utilizing EV-specific antibodies and nanoparticle probes to enhance scattering intensity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection technologies are used for EV analysis, then EV quantification can be achieved, but the methods require time-consuming and labor-intensive isolation and purification procedures
Solution Approach 1:
The invention extracts only the essential function of EV detection by using antibody-conjugated nanoparticles that directly bind to EV surface markers in crude samples, eliminating the need for time-consuming isolation and purification procedures while maintaining detection accuracy
Solution Approach 2:
The patent introduces antibody-conjugated nanoparticles as intermediaries that mediate between the EVs and the detection system, enabling direct quantification from crude samples without requiring complex purification steps
2Measurement precision
If conventional detection technologies are used for EV analysis, then EV quantification can be achieved, but the methods require relatively large sample volumes
Solution Approach 1:
The invention changes the detection parameters by using nanoparticle-based plasmonic resonance that amplifies the signal from individual EVs, enabling accurate quantification from very small sample volumes (as low as 1 µL) through enhanced light scattering and absorption effects
3Measurement precision
If conventional detection technologies are used for EV analysis, then EV quantification can be achieved, but the methods are complex and low-throughput
Solution Approach 1:
The patent merges multiple functions (EV capture, detection, and quantification) into a single nanoparticle-based assay that can be performed in one well without requiring complex multi-step procedures, thereby simplifying the overall detection method while maintaining accuracy
Solution Approach 2:
The invention creates a universal detection platform using antibody-conjugated nanoparticles that can detect different types of EVs by simply changing the antibody specificity, enabling a single method to serve multiple detection purposes without increasing complexity
4Measurement precision
If conventional detection technologies are used for EV analysis, then EV quantification can be achieved, but the methods have long turnaround times
Solution Approach 1:
The invention skips the intermediate purification steps entirely by using nanoparticle-based detection that works directly in crude samples, rushing through to the final quantification result in a single step and dramatically reducing turnaround time
5Measurement precision
If EV-enriched membrane proteins are used for standard EV analyses, then EV detection can be performed, but the proteins are present on EVs derived from most cell types and lack cancer specificity
Solution Approach 1:
The patent applies local quality by using different antibody specificities on different nanoparticles to simultaneously detect general EV markers and cancer-specific markers, enabling the detection system to distinguish tumor-derived EVs from normal EVs based on their unique protein composition profiles
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nPES assay provides rapid, ultrasensitive, and cost-effective detection and quantification of tumor-derived EVs, demonstrating high specificity and sensitivity for pancreatic cancer diagnosis and treatment monitoring, with potential for early detection and improved patient outcomes.
Implementation Method 1
contacting an EV containing sample with a surface conjugated with a first antibody directed to an EV molecule to separate said EV from the EV containing sample
Implementation Method 2
A nanoplasmon-enhanced scattering (nPES) assay using antibody-conjugated nanoparticles to form nanoplasmons for sensitive and specific detection of EVs, allowing direct analysis from small sample volumes without purification, utilizing EV-specific antibodies and nanoparticle probes to enhance scattering intensity
Data Source
AI summary
A rapid, ultrasensitive and inexpensive nanoplasmon-enhanced scattering (nPES) assay that directly quantifies tumor-derived EVs from as little as 1 μL of plasma is described herein. This assay uses binding of gold nanospheres and nanorods with EV- and tumor-derived EV-specificities to produce a local plasmon effect that enhances tumor-derived EV detection sensitivity and specificity. This nPES approach is also a non-invasive method for assessing pancreatic cancer stage and treatment response that can be easily refined for clinical use, and is readily adapted for diagnosis and monitoring of other conditions with disease-specific EV proteins.